Publications

Ahmed A, Joseph AM, Zhou J, Horn V, Uddin J, Lyu M, Goc J, Sockolow RE, Wing JB, Vivier E et al..  2024.  CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation.. Nature. 630(8018):976-983.

Ahmed A, Joseph AM, Zhou J, Horn V, Uddin J, Lyu M, Goc J, Sockolow RE, Wing JB, Vivier E et al..  2024.  CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation.. Nature. 630(8018):976-983.

Abramson J, Dobeš J, Lyu M, Sonnenberg GF.  2024.  The emerging family of RORγt+ antigen-presenting cells.. Nat Rev Immunol. 24(1):64-77.

Horn V, Sonnenberg GF.  2024.  Group 3 innate lymphoid cells in intestinal health and disease.. Nat Rev Gastroenterol Hepatol. 21(6):428-443.

Joseph AM, Ahmed A, Goc J, Horn V, Fiedler B, Garone D, Grigg JB, Uddin J, Teng F, Fritsch M et al..  2024.  RIPK3 and caspase-8 interpret cytokine signals to regulate ILC3 survival in the gut.. Mucosal Immunol.

Zhou W, Zhou JZ, Ahmed A, Kim MJoon, Guo C-J, Sonnenberg GF.  2025.  ILC3s sense gut microbiota through STING to initiate immune tolerance.. Immunity. 58(7):1762-1777.e7.

Towers BE, Sonnenberg GF.  2025.  Microniche control of innate lymphocyte biology in the gut.. Int Immunol.

Kang L, Sonnenberg GF.  2026.  Epigenetics control lineage decisions during hematopoiesis of innate lymphocytes.. Cell Mol Immunol.

Ahmed A, Sonnenberg GF.  2026.  Interleukin-23 biology linking mucosal immunity to autoimmune diseases and cancer.. Trends Immunol.